Multiple Sclerosis Relapsing-remitting
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis Relapsing-remitting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis
Completed real-world study assessing the health economic outcomes of Betaseron in relapsing forms of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2009-08-25Clinical Trial Update: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis [Phase 2]
A Phase II trial compared low- and high-dose alemtuzumab with high-dose Rebif in patients with early active relapsing-remitting multiple scl…
-
CLINICAL_TRIALS trial_result · 2009-06-18Clinical Trial Update: Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluates the safety and efficacy of combining natalizumab with Avonex for relapsing-remitting multiple sclerosis; the study…